Sculptor Capital LP Altimmune, Inc. Transaction History
Sculptor Capital LP
- $2.29 Billion
- Q1 2025
A detailed history of Sculptor Capital LP transactions in Altimmune, Inc. stock. As of the latest transaction made, Sculptor Capital LP holds 88,000 shares of ALT stock, worth $498,960. This represents 0.02% of its overall portfolio holdings.
Number of Shares
88,000Holding current value
$498,960% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding ALT
# of Institutions
203Shares Held
37.6MCall Options Held
2MPut Options Held
1.69M-
Black Rock Inc. New York, NY5.32MShares$30.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.41MShares$25 Million0.0% of portfolio
-
State Street Corp Boston, MA3.39MShares$19.2 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.75MShares$15.6 Million0.89% of portfolio
-
Geode Capital Management, LLC Boston, MA1.71MShares$9.67 Million0.0% of portfolio
About Altimmune, Inc.
- Ticker ALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,025,300
- Market Cap $278M
- Description
- Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...